| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |